Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
260M
-
Number of holders
-
834
-
Total 13F shares, excl. options
-
180M
-
Shares change
-
+6.77M
-
Total reported value, excl. options
-
$5.48B
-
Value change
-
+$195M
-
Put/Call ratio
-
1.32
-
Number of buys
-
268
-
Number of sells
-
-544
-
Price
-
$30.45
Significant Holders of Organon & Co. - Common Stock (OGN) as of Q4 2021
1,002 filings reported holding OGN - Organon & Co. - Common Stock as of Q4 2021.
Organon & Co. - Common Stock (OGN) has 834 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 180M shares
of 260M outstanding shares and own 69.15% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (28.8M shares), BlackRock Inc. (16.9M shares), STATE STREET CORP (9.36M shares), Bank of New York Mellon Corp (8.33M shares), JANUS HENDERSON GROUP PLC (7.11M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (5.77M shares), GEODE CAPITAL MANAGEMENT, LLC (5.39M shares), LORD, ABBETT & CO. LLC (4.48M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (4.43M shares), and Invesco Ltd. (4.02M shares).
This table shows the top 834 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.